<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Overall survival curve for patients with malignant peritoneal mesothelioma (MPM) treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Overall survival curve for patients with malignant peritoneal mesothelioma (MPM) treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy</h1>
<div class="graphic"><div class="figure"><div class="ttl">Overall survival curve for patients with malignant peritoneal mesothelioma (MPM) treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy</div><div class="cntnt"><img src="data:jpeg;base64,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"/></div><div class="graphic_lgnd">Kaplan-Meier actuarial overall survival (OS) curve for 211 patients with malignant peritoneal mesothelioma (MPM) treated with cytoreductive surgery (CRS)Â and hyperthermic intraperitoneal chemotherapy (HIPEC). The median actuarial overall survival was 38.4 months; the actuarial 5 and 10-year survivals were 41 and 26 percent, respectively.</div><div class="graphic_reference">Reproduced from: Alexander HR Jr, Bartlett DL, Pingpank JF, et al. Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma. Surgery 2013; 153:779. Illustration used with the permission of Elsevier Inc. All rights reserved.</div><div id="graphicVersion">Graphic 95960 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
